These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection. European Mycophenolate Mofetil Cooperative Study Group. Lancet; 1995 May; 345(8961):1321-5. PubMed ID: 7752752 [TBL] [Abstract][Full Text] [Related]
8. Oral ulcers associated with mycophenolate mofetil use in a renal transplant recipient. Weng RR; Foster CE; Hsieh LL; Patel PR Am J Health Syst Pharm; 2011 Apr; 68(7):585-8. PubMed ID: 21411799 [TBL] [Abstract][Full Text] [Related]
9. Incidence of leukopenia and cytomegalovirus disease in kidney transplants treated with mycophenolate mofetil combined with low cyclosporine and steroid doses. Moreso F; Serón D; Morales JM; Cruzado JM; Gil-Vernet S; Pérez JL; Fulladosa X; Andrés A; Grinyó JM Clin Transplant; 1998 Jun; 12(3):198-205. PubMed ID: 9642510 [TBL] [Abstract][Full Text] [Related]
10. Diagnosis and management of oral ulcerations associated with mycophenolate mofetil in kidney transplantation. Tenório JR; Tuma M; Martins F; Ortega KL; Cristelli M; Gallottini M Spec Care Dentist; 2020 Nov; 40(6):605-610. PubMed ID: 32950040 [TBL] [Abstract][Full Text] [Related]
11. Calcineurin inhibitor-free immunosuppression based on antithymocyte globulin and mycophenolate mofetil in cadaveric kidney transplantation: results after 5 years. Grinyó JM; Gil-Vernet S; Cruzado JM; Caldés A; Riera L; Serón D; Rama I; Torras J Transpl Int; 2003 Nov; 16(11):820-7. PubMed ID: 12879230 [TBL] [Abstract][Full Text] [Related]
12. Reasons for dose reduction of mycophenolate mofetil during the first year after renal transplantation and its impact on graft outcome. Vanhove T; Kuypers D; Claes KJ; Evenepoel P; Meijers B; Naesens M; Vanrenterghem Y; Cornelis T; Bammens B Transpl Int; 2013 Aug; 26(8):813-21. PubMed ID: 23746202 [TBL] [Abstract][Full Text] [Related]
14. A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group. Transplantation; 1996 Apr; 61(7):1029-37. PubMed ID: 8623181 [TBL] [Abstract][Full Text] [Related]
15. Comparing outcomes associated with dose manipulations of enteric-coated mycophenolate sodium versus mycophenolate mofetil in renal transplant recipients. Cooper M; Deering KL; Slakey DP; Harshaw Q; Arcona S; McCann EL; Rasetto FA; Florman SS Transplantation; 2009 Aug; 88(4):514-20. PubMed ID: 19696634 [TBL] [Abstract][Full Text] [Related]
16. Is cytomegalovirus infection related to mycophenolate mofetil after kidney transplantation? A case-control study. Sarmiento JM; Munn SR; Paya CV; Velosa JA; Nguyen JH Clin Transplant; 1998 Oct; 12(5):371-4. PubMed ID: 9787943 [TBL] [Abstract][Full Text] [Related]